Hjem › Akut bifænotypisk leukæmi › Washington › Spokane
Akut bifænotypisk leukæmi kliniske forsøg i Spokane, WA
3 studier for Akut bifænotypisk leukæmi søger deltagere på steder i og omkring Spokane (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RekruttererFase 2
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RekruttererFase 3
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Akut bifænotypisk leukæmi forsøg i andre byer
- Seattle, WA15 studier
- Houston, TX11 studier
- New York City, NY10 studier
- Atlanta, GA9 studier
- Durham, NC8 studier
- Memphis, TN7 studier
- Chicago, IL7 studier
- Charlotte, NC6 studier
- Aurora, CO6 studier
- Baldwin Park, CA6 studier
- Portland, OR6 studier
- Los Angeles, CA6 studier
Andre studier i Spokane
- Ikke-småcellet lungecancer12 studier
- Brystkræft8 studier
- Ægstockræft8 studier
- Colorektal kræft8 studier
- Parkinsons sygdom7 studier
- Prostatakræft6 studier
- Kronisk lymfatisk leukæmi6 studier
- Pladecellekræft i hoved og hals6 studier
- Kræft (alle typer)6 studier
- Tripelnegativ brystkræft5 studier
- Melanom5 studier
- Makuladegeneration5 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.